Haier Biomedical Launches Automated, Low-Carbon Cold Storage Solutions at Major Trade Events
Haier Biomedical Unveils Innovations for Sustainable Cold Storage
In a significant push towards sustainability and innovation in the life sciences industry, Haier Biomedical has recently revealed its latest automated cold storage products with low carbon emissions. This unveiling occurred at two prominent international trade fairs: the Europe Biobank Week 2026 in Prague and Interphex Week Tokyo 2026. These events mark pivotal moments for Haier Biomedical, showcasing its dedication to tailoring solutions that meet the evolving needs of global markets.
Meeting Local Needs with Global Innovation
At the heart of Haier Biomedical's strategy is its commitment to understanding and adapting to local market requirements. The company focuses specifically on automated, low-temperature storage solutions that enhance academic research and promote biobank development across Europe. Recently launched, the revolutionary HAB80-60KA/HAB80-60KB automated low-temperature sample storage system is specifically engineered to maintain biological samples at -80 °C and can effectively manage between 50,000 to over 200,000 samples. This system supports a variety of applications, including biobanking of critical specimens for diseases, populations, and research purposes.
The HAB80-60KA / HAB80-60KB system not only boasts a low-carbon design but also features a modular architecture that allows for scalable expansion. This innovative approach enhances the security of stored samples through independent dual refrigeration systems while ensuring the highest standards of performance. Users are equipped with an intuitive real-time monitoring system that tracks sample status throughout the storage process. This system allows for efficient inventory management and performance monitoring from any location, facilitating smoother daily operations for lab personnel.
Enhancing Collaboration and Integration
The Europe Biobank Week 2026 served as a platform where Haier Biomedical showcased its products in collaboration with the academic community. For instance, Professor Marco Agostini from the University of Padua demonstrated an innovative integration of classroom learning directly at Haier Biomedical's stand. This collaboration represents a significant bridge between academia and practical applications in the life sciences sector.
In addition, during the Interphex Week Tokyo 2026, Haier Biomedical introduced Japan-specific products, notably the DWL368BPST ultra-low temperature freezer, designed with space-constrained Japanese laboratories in mind. This compact freezer presents several enhancements over conventional models, including a dual cooling system for sample safety and a reduced energy consumption rate that is 26% lower than previous designs. Temperature uniformity is also optimized, with variations now maintained within ±2°C.
Commitment to Sustainable Growth
Driven by scenario-based innovation, Haier Biomedical is at the forefront of transforming life sciences infrastructure towards smarter, more automated, and sustainable solutions. By strengthening partnerships with universities, research institutions, biobanks, hospitals, and pharmaceutical companies, the organization fosters an open ecosystem for scientific advancement. Thanks to its long-term local operations, Haier Biomedical has garnered trust from users worldwide and is establishing itself as a reliable partner for sustainable growth in the life sciences industry.
As Haier Biomedical continues to roll out its innovative solutions and deepen its market penetration, it reinforces the notion that sustainable and efficient cold storage solutions will play a crucial role in the future of biomedical research and healthcare. The latest product introductions signify a step towards a greener future while ensuring that the life sciences community is well-equipped to tackle the challenges of tomorrow.